Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Reports from J.B. Treweek and co-researchers add new data to research in life sciences
January 14th, 2009
"One approach to treating drug abuse uses antidrug antibodies to immunize subjects against the illicit substance rather than administering the CNS site of action. At present, passive vaccination therapeutics that target the specific CNS has recognized efficacy in treating certain gross symptoms of drug misuse, namely, motor activation, self-administration, and overdose," scientists writing in the Journal of Medicinal Chemistry report. "However, the potential for antibodies to prevent drug-induced changes involving finer cognitive processes, such as benzodiazepine-associated amnesia, remains unexplored. To address this concept, a flunitrazepam hapten was...
Source: Vaccine Weekly (2009-01-14)
|
